menu search

Belite Bio Announces Pricing of $30 Million Underwritten Public Offering of American Depositary Shares and Warrants

Belite Bio Announces Pricing of $30 Million Underwritten Public Offering of American Depositary Shares and Warrants
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting retinal degenerative eye diseases which have significant unmet medical needs, today announced that it has priced an underwritten public offering of 2,000,000 American Depositary Shares […] The post Belite Bio Announces Pricing of $30 Million Underwritten Public Offering of American... Read More
Posted: May 31 2023, 00:49
Author Name: forextv
Views: 0814100

Search within

Pages Search Results: